BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35782752)

  • 1. Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.
    Vanni S; De Vita A; Gurrieri L; Fausti V; Miserocchi G; Spadazzi C; Liverani C; Cocchi C; Calabrese C; Bongiovanni A; Riva N; Mercatali L; Pieri F; Casadei R; Lucarelli E; Ibrahim T
    Ther Adv Med Oncol; 2022; 14():17588359221093973. PubMed ID: 35782752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives.
    Nishio J; Nakayama S
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.
    Vanni S; Fausti V; Fonzi E; Liverani C; Miserocchi G; Spadazzi C; Cocchi C; Calabrese C; Gurrieri L; Riva N; Recine F; Casadei R; Pieri F; Guerrieri AN; Serra M; Ibrahim T; Mercatali L; De Vita A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
    Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
    Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxofibrosarcoma primary cultures: molecular and pharmacological profile.
    De Vita A; Recine F; Mercatali L; Miserocchi G; Liverani C; Spadazzi C; Casadei R; Bongiovanni A; Pieri F; Riva N; Amadori D; Ibrahim T
    Ther Adv Med Oncol; 2017 Dec; 9(12):755-767. PubMed ID: 29449896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
    Nascimento AF; Bertoni F; Fletcher CD
    Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
    Lucarelli E; De Vita A; Bellotti C; Frisoni T; Vanni S; Guerrieri AN; Pannella M; Mercatali L; Gambarotti M; Duchi S; Miserocchi G; Maioli M; Liverani C; Ibrahim T
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Dangerous" cutaneous polyp. Exophytic cutaneous myxofibrosarcoma].
    Paredes BE; Mentzel T; Denfeld R
    Hautarzt; 2012 Sep; 63(9):719-23. PubMed ID: 22552841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy.
    Zagars GK; Mullen JR; Pollack A
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):983-94. PubMed ID: 8600111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course].
    Mentzel T; Katenkamp D; Fletcher CD
    Pathologe; 1996 Mar; 17(2):116-21. PubMed ID: 8650138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma.
    Sun H; Liu J; Hu F; Xu M; Leng A; Jiang F; Chen K
    Front Genet; 2023; 14():1109491. PubMed ID: 36873946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myxofibrosarcoma (myxoid malignant fibrous histiocytoma) showing cutaneous presentation: report of two cases.
    Fujimura T; Okuyama R; Terui T; Okuno K; Masu A; Masu T; Chiba S; Kunii T; Tagami H; Aiba S
    J Cutan Pathol; 2005 Aug; 32(7):512-5. PubMed ID: 16008697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
    Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
    Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant.
    Mentzel T; Calonje E; Wadden C; Camplejohn RS; Beham A; Smith MA; Fletcher CD
    Am J Surg Pathol; 1996 Apr; 20(4):391-405. PubMed ID: 8604805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology, classification, and management of recurrent myxofibrosarcoma 21 years after resection.
    Palumbo BT; Henderson E; Letson GD; Cheong D
    Am J Orthop (Belle Mead NJ); 2011 Nov; 40(11):579-82. PubMed ID: 22263212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-needle aspiration in myxofibrosarcoma: experience of Institut Curie.
    Colin P; Lagacé R; Caillaud JM; Sastre-Garau X; Klijanienko J
    Diagn Cytopathol; 2010 May; 38(5):343-6. PubMed ID: 19899126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft tissue sarcomas with complex genomic profiles.
    Guillou L; Aurias A
    Virchows Arch; 2010 Feb; 456(2):201-17. PubMed ID: 20217954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myxofibrosarcoma presenting in the skin: clinicopathological features and differential diagnosis with cutaneous myxoid neoplasms.
    Mansoor A; White CR
    Am J Dermatopathol; 2003 Aug; 25(4):281-6. PubMed ID: 12876484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine needle aspiration biopsy of primary breast myxofibrosarcoma: a case report.
    Klopcic U; Lamovec J; Luzar B
    Acta Cytol; 2009; 53(1):109-12. PubMed ID: 19248565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxofibrosarcoma: cytomorphologic findings and differential diagnosis on fine needle aspiration.
    Olson MT; Ali SZ
    Acta Cytol; 2012; 56(1):15-24. PubMed ID: 22236741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.